<![CDATA[Genmab — Juni 2012]]>14 dage gammel artikel, men dog interessant for Genmab: http://www.bloomberg.com/news/2012-05-23/glaxo-avoids-market-for-lemons-by-acquiring-its-collaborators.html

]]>https://dev.proinvestor.com/forum/topic/451447/genmab-juni-2012RSS for NodeFri, 19 Jun 2026 10:06:12 GMTSun, 10 Jun 2012 12:28:18 GMT60<![CDATA[Reply to Genmab — Juni 2012 on Tue, 26 Jun 2012 19:24:10 GMT]]>og Credit agricole og enskilda er også med i kampen

]]>https://dev.proinvestor.com/forum/post/10067523https://dev.proinvestor.com/forum/post/10067523Tue, 26 Jun 2012 19:24:10 GMT<![CDATA[Reply to Genmab — Juni 2012 on Tue, 26 Jun 2012 19:22:47 GMT]]>carnegie fik taget en del igen idag 32K netto.

]]>https://dev.proinvestor.com/forum/post/10067521https://dev.proinvestor.com/forum/post/10067521Tue, 26 Jun 2012 19:22:47 GMT<![CDATA[Reply to Genmab — Juni 2012 on Fri, 15 Jun 2012 11:22:31 GMT]]>man skal en time og nogle minutter ind i den som også står skrevet i debatten 32 min fra slutningen

]]>https://dev.proinvestor.com/forum/post/10067522https://dev.proinvestor.com/forum/post/10067522Fri, 15 Jun 2012 11:22:31 GMT<![CDATA[Reply to Genmab — Juni 2012 on Fri, 15 Jun 2012 11:18:33 GMT]]>http://myeloma.org/ArticlePage.action?articleId=3707 om Daratumumab. Meget spændende

]]>https://dev.proinvestor.com/forum/post/10067520https://dev.proinvestor.com/forum/post/10067520Fri, 15 Jun 2012 11:18:33 GMT